SMTL ID : 8hog.1

Crystal structure of Bcl-2 in complex with sonrotoclax

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 98I: ~{N}-[4-[(4-methyl-4-oxidanyl-cyclohexyl)methylamino]-3-nitro-phenyl]sulfonyl-4-[2-[(2~{S})-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-(1~{H}-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide(Non-covalent)

98I.1: 18 residues within 4Å: Chain A: Q.54, A.55, D.58, F.59, R.62, Y.63, D.66, F.67, M.70, L.92, N.98, W.99, G.100, R.101, V.103, A.104, F.153, Y.157 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:D.58, A:F.59, A:F.59, A:F.59, A:Y.63, A:F.67, A:F.67, A:W.99, A:R.101, A:Y.157, A:Y.157, A:Y.157 Hydrogen bonds: A:D.58, A:N.98, A:N.98, A:W.99, A:G.100, A:Y.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy. Blood (2024)

Release Date

2024-01-17

Peptides

Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Apoptosis regulator Bcl-2